Microarray technology in obstetrics and gynecology: A guide for clinicians

American Journal of Obstetrics and Gynecology

Volumn 195, Issue 2, 2006, Pages 364-372

  Ward, Kenneth ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Gene expression; Gene mapping; Genomics; Microarray

Indexed keywords

COMPARATIVE GENOMIC HYBRIDIZATION; DIAGNOSTIC PROCEDURE; DNA MICROARRAY; DNA SEQUENCE; GENE EXPRESSION; GENE MAPPING; GENOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; MICROARRAY ANALYSIS; MICROORGANISM DETECTION; NEWBORN SCREENING; PRACTICE GUIDELINE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

CHROMOSOME MAPPING; FEMALE; GENE EXPRESSION PROFILING; GENITAL NEOPLASMS, FEMALE; GYNECOLOGY; HUMANS; OBSTETRICS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; SOFTWARE;

EID: 33746537117     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.12.014     Document Type: Review

References (85)

1. Ewis A.A., Zhelev Z., Bakalova R., Fukuoka S., Shinohara Y., Ishikawa M., et al. A history of microarrays in biomedicine. Expert Rev Mol Diagn 5 (2005) 315-328
2. Fodor S.P., Read J.L., Pirrung M.C., Stryer L., Lu A.T., and Solas D. Light-directed, spatially addressable parallel chemical synthesis. Science 251 (1991) 767-773
3. Auburn R.P., Kreil D.P., Meadows L.A., Fischer B., Matilla S.S., and Russell S. Robotic spotting of cDNA and oligonucleotide microarrays. Trends Biotechnol 23 (2005) 374-379
4. Mandal M.N., Heckenlively J.R., Burch T., Chen L., Vasireddy V., Koenekoop R.K., et al. Sequencing arrays for screening multiple genes associated with early-onset human retinal degenerations on a high-throughput platform. Invest Ophthalmol Vis Sci 46 (2005) 3355-3362
5. Davignon L., Walter E.A., Mueller K.M., Barrozo C.P., Stenger D.A., and Lin B. Use of resequencing oligonucleotide microarrays for identification of Streptococcus pyogenes and associated antibiotic resistance determinants. J Clin Microbiol 43 (2005) 5690-5695
6. Vissers L.E., Veltman J.A., van Kessel A.G., and Brunner H.G. Identification of disease genes by whole genome CGH arrays. Hum Mol Genet 14 Spec No 2 (2005) R215-R223
7. Lapierre J.M., and Tachdjian G. Detection of chromosomal abnormalities by comparative genomic hybridization. Curr Opin Obstet Gynecol 17 (2005) 171-177
8. Baggerly K.A., Coombes K.R., Hess K.R., Stivers D.N., Abruzzo L.V., and Zhang W. Identifying differentially expressed genes in cDNA microarray experiments. J Comput Biol 8 (2001) 639-659
9. Imbeaud S., and Auffray C. 'The 39 steps' in gene expression profiling: critical issues and proposed best practices for microarray experiments. Drug Discov Today 10 (2005) 1175-1182
10. Mockler T.C., Chan S., Sundaresan A., Chen H., Jacobsen S.E., and Ecker J.R. Applications of DNA tiling arrays for whole-genome analysis. Genomics 85 (2005) 1-15
11. Broberg P. A comparative review of estimates of the proportion unchanged genes and the false discovery rate. BMC Bioinformatics 6 (2005) 199
12. Dechering K.J. The transcriptome's drugable frequenters. Drug Discov Today 10 (2005) 857-864
13. Bild A.H., Yao G., Chang J.T., Wang Q., Potti A., Chasse D., et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439 (2006) 353-357
14. Marquez Mdel C., Perez P.P., and Lagunez-Otero J. An evolving neural network for the interpretation of gene expression patterns. Omics 9 (2005) 209-217
15. Di X., Matsuzaki H., Webster T.A., Hubbell E., Liu G., Dong S., et al. Dynamic model based algorithms for screening and genotyping over 100 K SNPs on oligonucleotide microarrays. Bioinformatics 21 (2005) 1958-1963
16. Dean M. Approaches to identify genes for complex human diseases: lessons from Mendelian disorders. Hum Mutat 22 (2003) 261-274
17. Hirschhorn J.N., Lohmueller K., Byrne E., and Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 4 (2002) 45-61
18. Tabor H.K., Risch N.J., and Myers R.M. Opinion: Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet 3 (2002) 391-397
19. Hao K., Xu X., Laird N., Wang X., and Xu X. Power estimation of multiple SNP association test of case-control study and application. Genet Epidemiol 26 (2004) 22-30
20. Patil N., Berno A.J., Hinds D.A., Barrett W.A., Doshi J.M., Hacker C.R., et al. Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 294 (2001) 1719-1723
21. Morton N.E. Linkage disequilibrium maps and association mapping. J Clin Invest 115 (2005) 1425-1430
22. Farrall M., and Morris A.P. Gearing up for genome-wide gene-association studies. Hum Mol Genet 14 Spec No 2 (2005) R157-R162
23. Freedman M.L., Reich D., Penney K.L., McDonald G.J., Mignault A.A., Patterson N., et al. Assessing the impact of population stratification on genetic association studies. Nat Genet 36 (2004) 388-393
24. Koller D.L., Peacock M., Lai D., Foroud T., and Econs M.J. False positive rates in association studies as a function of degree of stratification. J Bone Miner Res 19 (2004) 1291-1295
25. Olivier M. A haplotype map of the human genome. Physiol Genomics 13 (2003) 3-9
26. Zhang K., Calabrese P., Nordborg M., and Sun F. Haplotype block structure and its applications to association studies: power and study designs. Am J Hum Genet 71 (2002) 1386-1394
27. Risch N., and Teng J. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling. Genome Res 8 (1998) 1273-1288
28. Green N.S., and Pass K.A. Neonatal screening by DNA microarray: spots and chips. Nat Rev Genet 6 (2005) 147-151
29. Hartmann O. Quality control for microarray experiments. Methods Inf Med 44 (2005) 408-413
30. Schmidt A., Groth P., Haendler B., Hess-Stumpp H., Kratzschmar J., Seidel H., et al. Gene expression during the implantation window: microarray analysis of human endometrial samples. Ernst Schering Res Found Workshop 52 (2005) 139-157
31. Cebula T.A., Jackson S.A., Brown E.W., Goswami B., and LeClerc J.E. Chips and SNPs, bugs and thugs: a molecular sleuthing perspective. J Food Prot 68 (2005) 1271-1284
32. Bucca G., Carruba G., Saetta A., Muti P., Castagnetta L., and Smith C.P. Gene expression profiling of human cancers. Ann N Y Acad Sci 1028 (2004) 28-37
33. Brentani R.R., Carraro D.M., Verjovski-Almeida S., Reis E.M., Neves E.J., de Souza S.J., et al. Gene expression arrays in cancer research: methods and applications. Crit Rev Oncol Hematol 54 (2005) 95-105
34. Cuperlovic-Culf M., Belacel N., and Ouellette R.J. Determination of tumour marker genes from gene expression data. Drug Discov Today 10 (2005) 429-437
35. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., et al. Genes that mediate breast cancer metastasis to lung. Nature 436 (2005) 518-524
36. Nambiar S., Mirmohammadsadegh A., Doroudi R., Gustrau A., Marini A., Roeder G., et al. Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays. Arch Dermatol 141 (2005) 165-173
37. Chang J.C., Hilsenbeck S.G., and Fuqua S.A. Genomic approaches in the management and treatment of breast cancer. Br J Cancer 92 (2005) 618-624
38. Fuqua S.A., Chang J.C., and Hilsenbeck S.G. Genomic approaches to understanding and treating breast cancer. Breast Dis 19 (2004) 35-46
39. Brenton J.D., Carey L.A., Ahmed A.A., and Caldas C. Molecular classification and molecular forecasting of breast cancer: ready for clinical application?. J Clin Oncol 23 (2005) 7350-7360
40. Jeffrey S.S., Lonning P.E., and Hillner B.E. Genomics-based prognosis and therapeutic prediction in breast cancer. J Natl Compr Canc Netw 3 (2005) 291-300
41. Brown R.E. Morphoproteomics: exposing protein circuitries in tumors to identify potential therapeutic targets in cancer patients. Expert Rev Proteomics 2 (2005) 337-348
42. Schmith V.D., Campbell D.A., Sehgal S., Anderson W.H., Burns D.K., Middleton L.T., et al. Pharmacogenetics and disease genetics of complex diseases. Cell Mol Life Sci 60 (2003) 1636-1646
43. Burczynski M.E., Oestreicher J.L., Cahilly M.J., Mounts D.P., Whitley M.Z., Speicher L.A., et al. Clinical pharmacogenomics and transcriptional profiling in early phase oncology clinical trials. Curr Mol Med 5 (2005) 83-102
44. Luhe A., Suter L., Ruepp S., Singer T., Weiser T., and Albertini S. Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?. Mutat Res 575 (2005) 102-115
45. Yengi L.G. Systems biology in drug safety and metabolism: integration of microarray, real-time PCR and enzyme approaches. Pharmacogenomics 6 (2005) 185-192
46. Nuwaysir E.F., Bittner M., Trent J., Barrett J.C., and Afshari C.A. Microarrays and toxicology: the advent of toxicogenomics. Mol Carcinog 24 (1999) 153-159
47. Gant T.W., and Zhang S.D. In pursuit of effective toxicogenomics. Mutat Res 575 (2005) 4-16
48. Shioda T. Application of DNA microarray to toxicological research. J Environ Pathol Toxicol Oncol 23 (2004) 13-31
49. Bryant P.A., Venter D., Robins-Browne R., and Curtis N. Chips with everything: DNA microarrays in infectious diseases. Lancet Infect Dis 4 (2004) 100-111
50. Longley D.B., and Johnston P.G. Molecular mechanisms of drug resistance. J Pathol 205 (2005) 275-292
51. McGuire K., and Glass E.J. The expanding role of microarrays in the investigation of macrophage responses to pathogens. Vet Immunol Immunopathol 105 (2005) 259-275
52. Bretz F., Landgrebe J., and Brunner E. Multiplicity issues in microarray experiments. Methods Inf Med 44 (2005) 431-437
53. Curtis R.K., Oresic M., and Vidal-Puig A. Pathways to the analysis of microarray data. Trends Biotechnol 23 (2005) 429-435
54. Krallinger M., Erhardt R.A., and Valencia A. Text-mining approaches in molecular biology and biomedicine. Drug Discov Today 10 (2005) 439-445
55. Kreil D.P., and Russell R.R. There is no silver bullet-a guide to low-level data transforms and normalisation methods for microarray data. Brief Bioinform 6 (2005) 86-97
56. Qin L., Rueda L., Ali A., and Ngom A. Spot detection and image segmentation in DNA microarray data. Appl Bioinformatics 4 (2005) 1-11
57. Reimers M. Statistical analysis of microarray data. Addict Biol 10 (2005) 23-35
58. Sherlock G., and Ball C.A. Storage and retrieval of microarray data and open source microarray database software. Mol Biotechnol 30 (2005) 239-251
59. White C.A., and Salamonsen L.A. A guide to issues in microarray analysis: application to endometrial biology. Reproduction 130 (2005) 1-13
60. Armstrong N.J., and van de Wiel M.A. Microarray data analysis: from hypotheses to conclusions using gene expression data. Cell Oncol 26 (2004) 279-290
61. Liang Y., and Kelemen A. Associating phenotypes with molecular events: recent statistical advances and challenges underpinning microarray experiments. Funct Integr Genomics 6 (2006) 1-13
62. Kanehisa M. The KEGG database. Novartis Found Symp 247 (2002) 91-101 discussion 101-3, 119-28, 244-52
63. Bracken M.B. Genomic epidemiology of complex disease: the need for an electronic evidence-based approach to research synthesis. Am J Epidemiol 162 (2005) 297-301
64. Dobson P.D., Cai Y.D., Stapley B.J., and Doig A.J. Prediction of protein function in the absence of significant sequence similarity. Curr Med Chem 11 (2004) 2135-2142
65. Stoll D., Templin M.F., Bachmann J., and Joos T.O. Protein microarrays: applications and future challenges. Curr Opin Drug Discov Devel 8 (2005) 239-252
66. Angenendt P. Progress in protein and antibody microarray technology. Drug Discov Today 10 (2005) 503-511
67. Adams E.W., Ratner D.M., Bokesch H.R., McMahon J.B., O'Keefe B.R., and Seeberger P.H. Oligosaccharide and glycoprotein microarrays as tools in HIV glycobiology; glycan-dependent gp120/protein interactions. Chem Biol 11 (2004) 875-881
68. Hirabayashi J. Oligosaccharide microarrays for glycomics. Trends Biotechnol 21 (2003) 141-143 discussion 143
69. Uttamchandani M., Walsh D.P., Yao S.Q., and Chang Y.T. Small molecule microarrays: recent advances and applications. Curr Opin Chem Biol 9 (2005) 4-13
70. Fang Y., Lahiri J., and Picard L. G protein-coupled receptor microarrays for drug discovery. Drug Discov Today 8 (2003) 755-761
71. Fiorini G.S., and Chiu D.T. Disposable microfluidic devices: fabrication, function, and application. Biotechniques 38 (2005) 429-446
72. Haab B.B., Dunham M.J., and Brown P.O. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2 (2001) RESEARCH0004
73. Kersten B., Wanker E.E., Hoheisel J.D., and Angenendt P. Multiplex approaches in protein microarray technology. Expert Rev Proteomics 2 (2005) 499-510
74. Lueking A., Cahill D.J., and Mullner S. Protein biochips: a new and versatile platform technology for molecular medicine. Drug Discov Today 10 (2005) 789-794
75. Wheeler D.B., Carpenter A.E., and Sabatini D.M. Cell microarrays and RNA interference chip away at gene function. Nat Genet 37 Suppl (2005) S25-S30
76. Taylor M.F. Antisense oligonucleotides for target validation and gene function determination. IDrugs 2 (1999) 777-781
77. Vanhecke D., and Janitz M. Functional genomics using high-throughput RNA interference. Drug Discov Today 10 (2005) 205-212
78. Bertone P., Gerstein M., and Snyder M. Applications of DNA tiling arrays to experimental genome annotation and regulatory pathway discovery. Chromosome Res 13 (2005) 259-274
79. Shoemaker D.D., Schadt E.E., Armour C.D., He Y.D., Garrett-Engele P., McDonagh P.D., et al. Experimental annotation of the human genome using microarray technology. Nature 409 (2001) 922-927
80. Johnson J.M., Edwards S., Shoemaker D., and Schadt E.E. Dark matter in the genome: evidence of widespread transcription detected by microarray tiling experiments. Trends Genet 21 (2005) 93-102
81. Fedor H.L., and De Marzo A.M. Practical methods for tissue microarray construction. Methods Mol Med 103 (2005) 89-101
82. Tzankov A., Went P., Zimpfer A., and Dirnhofer S. Tissue microarray technology: principles, pitfalls and perspectives-lessons learned from hematological malignancies. Exp Gerontol 40 (2005) 737-744
83. Long W.H., Xiao H.S., Gu X.M., Zhang Q.H., Yang H.J., Zhao G.P., et al. A universal microarray for detection of SARS coronavirus. J Virol Methods 121 (2004) 57-63
84. Wong C.W., Albert T.J., Vega V.B., Norton J.E., Cutler D.J., Richmond T.A., et al. Tracking the evolution of the SARS coronavirus using high-throughput, high-density resequencing arrays. Genome Res 14 (2004) 398-405
85. Striebel H.M., Birch-Hirschfeld E., Egerer R., and Foldes-Papp Z. Virus diagnostics on microarrays. Curr Pharm Biotechnol 4 (2003) 401-415